PATENT CLAIM ANALYSIS

Application Number: 16060250
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["544", "278000"]

Abstract:
The present invention relates to a novel dihydropyranopyrimidinone derivative, a tautomer thereof, a stereoisomer thereof and their mixture, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating a tankyrase-related disease, which contains the same as an active ingredient.

Claim (Index 2):
The compound of Chemical Formula 1 according to  claim 1 , wherein\n X is CHR 4 ; Y is N or C; l is 1 or 2; R 1  is hydrogen or hydroxyl {herein, if Y is N, R 1  is null}; R 2  is or heteroaryl;\n R 4  is hydrogen; \n m is 0, 1, or 2; \n n is 0, 1, 2, or 3; \n each of R 5  is independently \u2014Z\u2014(CH 2 ) p \u2014R 6 , halo or C 1-6  hydroxyalkyl; \n Z is \u2014O\u2014 or null; \n p is 0, 1, 2, or 3; \n R 6  is hydrogen, hydroxyl, \u2014OR 8 , \u2014NR 9 R 10 , C 1-6  dihydroxyalkyl, heterocyclyl or heteroaryl; \n R 8  is hydrogen, C 1-6  alkyl or heterocyclyl; and \n each of R 9  and R 10  is independently hydrogen, C 1-6  alkyl or C 3-6  cycloalkyl; \n a tautomer thereof, a stereoisomer thereof and their mixture, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.32432
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15325651', '15325692', '14154161', '14154173', '14154170']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7862420943011573
- 35 USC 102 Novelty (BERT): 0.5551938678172276
- Combined Prediction Score: 0.7631372716527643
- Mean Citation Score: 369.913976
- Max Citation Score: 422.80225
- Similarity Product: 328.92079493930936

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test